Additionally, FXR serves as a negative regulator of hepatic inflammation, with reciprocal suppression observed between FXR and NF-κB signaling pathways, indicating the connection of BA receptors and inflammation in HCC development [59,79]. Here, NR1H4 is linked to hepatocellular carcinoma.